Skip to content

Related video: How Replit positioned itself for the AI coding agent era, Y Combinator

AI breast cancer risk test launches nationwide using mammogram data

Inc. · · 20-second read

Share

Top comments from YouTube.

    This story is from October 2, 2026. For the latest, see today's news.

    October 2, 2026 · AI Startups

    A company called Clairity has launched an AI-powered test called Clairity Breast that estimates a woman's risk of developing breast cancer using an existing mammogram image. The test, priced at $249, is now available across the United States.

    Unlike traditional risk assessments that rely on family history or genetic testing, this tool analyzes patterns in mammogram imaging directly, aiming to give earlier and more personalized risk information without requiring additional scans or invasive procedures.

    Read the full story at Inc.

    This is an AI-written summary. The original reporting belongs to Inc.. How we write these · Spot a mistake?

    Get the AI brief every morning.

    The five AI stories that matter each morning: startups, money, jobs, tech and what's coming next. Free, and one click to unsubscribe. See our Privacy Policy.